136 related articles for article (PubMed ID: 7534672)
1. Potential role of CD28-B7 interactions in the growth of myeloma plasma cells.
Kornbluth J
Curr Top Microbiol Immunol; 1995; 194():43-9. PubMed ID: 7534672
[No Abstract] [Full Text] [Related]
2. Malignant plasma cell lines express a functional CD28 molecule.
Zhang XG; Olive D; Devos J; Rebouissou C; Ghiotto-Ragueneau M; Ferlin M; Klein B
Leukemia; 1998 Apr; 12(4):610-8. PubMed ID: 9557621
[TBL] [Abstract][Full Text] [Related]
3. Revealing the atomistic details behind the binding of B7-1 to CD28 and CTLA-4: A comprehensive protein-protein modelling study.
Ganesan A; Moon TC; Barakat KH
Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2764-2778. PubMed ID: 30251665
[TBL] [Abstract][Full Text] [Related]
4. CD28 expressed on malignant plasma cells induces a prosurvival and immunosuppressive microenvironment.
Nair JR; Carlson LM; Koorella C; Rozanski CH; Byrne GE; Bergsagel PL; Shaughnessy JP; Boise LH; Chanan-Khan A; Lee KP
J Immunol; 2011 Aug; 187(3):1243-53. PubMed ID: 21715687
[TBL] [Abstract][Full Text] [Related]
5. Mutational analysis and an alternatively spliced product of B7 defines its CD28/CTLA4-binding site on immunoglobulin C-like domain.
Guo Y; Wu Y; Zhao M; Kong XP; Liu Y
J Exp Med; 1995 Apr; 181(4):1345-55. PubMed ID: 7535334
[TBL] [Abstract][Full Text] [Related]
6. Identification of residues in the V domain of CD80 (B7-1) implicated in functional interactions with CD28 and CTLA4.
Fargeas CA; Truneh A; Reddy M; Hurle M; Sweet R; Sékaly RP
J Exp Med; 1995 Sep; 182(3):667-75. PubMed ID: 7544393
[TBL] [Abstract][Full Text] [Related]
7. B7-CD28 interaction is a late acting co-stimulatory signal for human T cell responses.
Zhang YQ; Joost van Neerven RJ; Van Gool SW; Coorevits L; de Boer M; Ceuppens JL
Int Immunol; 1997 Aug; 9(8):1095-102. PubMed ID: 9263006
[TBL] [Abstract][Full Text] [Related]
8. [Multiple myeloma. Mechanisms of proliferation and neoplastic progression and their clinical implications].
Boccadoro M; Battaglio S; Dianzani U; Frieri R; Gallone G; Massaia M; Omedè P; Palumbo A; Pileri A
Haematologica; 1991 Jun; 76 Suppl 3():100-6. PubMed ID: 1752506
[No Abstract] [Full Text] [Related]
9. CD28-mediated regulation of multiple myeloma cell proliferation and survival.
Bahlis NJ; King AM; Kolonias D; Carlson LM; Liu HY; Hussein MA; Terebelo HR; Byrne GE; Levine BL; Boise LH; Lee KP
Blood; 2007 Jun; 109(11):5002-10. PubMed ID: 17311991
[TBL] [Abstract][Full Text] [Related]
10. Cutting edge: B7/CD28 interactions regulate cell cycle progression independent of the strength of TCR signaling.
Bonnevier JL; Mueller DL
J Immunol; 2002 Dec; 169(12):6659-63. PubMed ID: 12471093
[TBL] [Abstract][Full Text] [Related]
11. Alpha(v)beta(3) integrin engagement enhances cell invasiveness in human multiple myeloma.
Ria R; Vacca A; Ribatti D; Di Raimondo F; Merchionne F; Dammacco F
Haematologica; 2002 Aug; 87(8):836-45. PubMed ID: 12161360
[TBL] [Abstract][Full Text] [Related]
12. Role of CD28-B7 interactions in generation and maintenance of CD8 T cell memory.
Suresh M; Whitmire JK; Harrington LE; Larsen CP; Pearson TC; Altman JD; Ahmed R
J Immunol; 2001 Nov; 167(10):5565-73. PubMed ID: 11698427
[TBL] [Abstract][Full Text] [Related]
13. Multiple myeloma: the biology of malignant plasma cells.
Barker HF; Ball J; Drew M; Franklin IM
Blood Rev; 1993 Mar; 7(1):19-23. PubMed ID: 8467228
[TBL] [Abstract][Full Text] [Related]
14. B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells.
Caux C; Vanbervliet B; Massacrier C; Azuma M; Okumura K; Lanier LL; Banchereau J
J Exp Med; 1994 Nov; 180(5):1841-7. PubMed ID: 7525840
[TBL] [Abstract][Full Text] [Related]
15. A theoretical framework for quantitative analysis of the molecular basis of costimulation.
Jansson A; Barnes E; Klenerman P; Harlén M; Sørensen P; Davis SJ; Nilsson P
J Immunol; 2005 Aug; 175(3):1575-85. PubMed ID: 16034096
[TBL] [Abstract][Full Text] [Related]
16. New protein steals the show as 'costimulator' of T cells.
Cohen J
Science; 1993 Nov; 262(5135):844-5. PubMed ID: 7694360
[No Abstract] [Full Text] [Related]
17. Tumor-infiltrating T lymphocytes from renal-cell carcinoma express B7-1 (CD80): T-cell expansion by T-T cell co-stimulation.
Thurnher M; Radmayr C; Hobisch A; Böck G; Romani N; Bartsch G; Klocker H
Int J Cancer; 1995 Sep; 62(5):559-64. PubMed ID: 7545143
[TBL] [Abstract][Full Text] [Related]
18. In situ expression of B7 and CD28 receptor families in human malignant melanoma: relevance for T-cell-mediated anti-tumor immunity.
Denfeld RW; Dietrich A; Wuttig C; Tanczos E; Weiss JM; Vanscheidt W; Schöpf E; Simon JC
Int J Cancer; 1995 Jul; 62(3):259-65. PubMed ID: 7543078
[TBL] [Abstract][Full Text] [Related]
19. Costimulation of T-cell activation and virus production by B7 antigen on activated CD4+ T cells from human immunodeficiency virus type 1-infected donors.
Haffar OK; Smithgall MD; Bradshaw J; Brady B; Damle NK; Linsley PS
Proc Natl Acad Sci U S A; 1993 Dec; 90(23):11094-8. PubMed ID: 7504294
[TBL] [Abstract][Full Text] [Related]
20. New molecules on dendritic cells and their interactions with T lymphocytes.
Hart DN; Starling GC; Egner W; Hock BD; McLellan AD; McKenzie JL; Williams LA; Simmons DL
Adv Exp Med Biol; 1995; 378():351-4. PubMed ID: 8526091
[No Abstract] [Full Text] [Related]
[Next] [New Search]
